✦ LIBER ✦

819 HEALTH-RELATED QUALITY OF LIFE (HRQOL) WITH ALBINTERFERON ALFA-2B PLUS RIBAVIRIN IN IFN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C

✍ Scribed by S. Pianko; E. Yoshida; S. Zeuzem; Y. Benhamou; V. Bain; E. Pulkstenis; J.G. McHutchison; G.M. Subramanian

Book ID: 117376745
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 69 KB
Volume: 48
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(08)60821-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[779] ANTIVIRAL RESPONSE AT WEEK 12 FOLL

[779] ANTIVIRAL RESPONSE AT WEEK 12 FOLLOWING COMPLETION OF TREATMENT WITH ALBINTERFERON a-2b PLUS RIBAVIRIN IN GENOTYPE 1, IFN-NAIVE, CHRONIC HEPATITIS C PATIENTS

✍ S. Zeuzem; Y. Benhamou; V. Bain; D. Shouval; S. Pianko; R. Flisiak; M. Grigoresc 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 133 KB

818 VIRAL KINETICS AND PHARMACODYNAMICS

818 VIRAL KINETICS AND PHARMACODYNAMICS OF ALBINTERFERON ALFA-2B IN INTERFERON TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1, CHRONIC HEPATITIS C

✍ A.U. Neumann; L. Rozenberg; V.G. Bain; J.G. McHutchison; E. Pulkstenis; G.M. Sub 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

817 POSITIVE PREDICTIVE VALUE OF EARLY A

817 POSITIVE PREDICTIVE VALUE OF EARLY ANTIVIRAL RESPONSE PROFILE WITH ALBINTERFERON ALFA-2B IN IFN-NAIVE PATIENTS WITH GENOTYPE 1, CHRONIC HEPATITIS C

✍ A.U. Neumann; S. Zeuzem; E. Yoshida; Y. Benhamou; S. Pianko; J.G. McHutchison; E 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Treatment of insulin resistance with met

Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin

✍ Manuel Romero-Gómez; Moisés Diago; Raúl J. Andrade; José L. Calleja; Javier Salm 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB 👁 1 views

Insulin resistance affects sustained virological response (SVR) in chronic hepatitis C. To know whether adding metformin to standard antiviral treatment improves SVR, we conducted a prospective, multicentered, randomized, double-blinded, placebo-controlled trial in 19 Spanish hospitals, including 12

Efficacy of 24 weeks treatment with pegi

Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia

✍ Stefan Zeuzem; Maria Buti; Peter Ferenci; Jan Sperl; Yves Horsmans; Janusz Cianc 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Viral kinetics in genotype 1 chronic hep

Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin

✍ Maria Buti; Francisco Sanchez-Avila; Yoav Lurie; Carlos Stalgis; Auristela Valdé 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB